Biopharma Continues to Buoy the IPO Market
Four more companies have either gone public or filed plans in the past week.
Recent Articles
Ken Tropin Plays the Long Game With Graham Capital
“They come to us because we’re known as having a very strict risk culture and philosophy.”
Eighteen Months ago, I Wrote About How AI Agents Could Be Used to Run an Entire Investment Business
Three months ago, I found a manager who has been doing just this for two decades without LLMs
Angelo Calvello
August 24, 2026
